The Haematology department provides a full range of services for the diagnosis and management of patients with all types of blood disorders, including cancers of the blood.

The department, which has close links to the University of Cambridge, is internationally renowned for its clinical expertise, laboratory diagnostic work and scientific research into the understanding and treatment of blood disorders. We are extensively involved in undergraduate and postgraduate training.

The Centre includes the East Anglia Blood and Marrow Transplant Unit which provides a comprehensive service for the treatment of cancer. We offer high-dose therapy with bone marrow and peripheral blood stem-cell support, plus a dedicated outpatient department with day-case facilities for the treatment of patients undergoing transfusion, chemotherapy and apheresis. 

Recently, the Cambridge Cellular Therapy Laboratory (CCTL) team have joined the cancer directorate. CCTL is a vital part of the Bone Marrow Transplant service at CUH (they also provide a service to Ipswich hospital and Norfolk & Norwich Hospital). CCTL offers the assessment, processing and storage of cells collected from bone marrow and peripheral blood intended for autologous or allogeneic transplant.

In addition, non-malignant Haematology including Haemophilia, Thrombophilia and Thrombosis services have also joined the cancer directorate.

The Haemophilia and Thrombophilia centre specialises in the diagnosis and management of people with inherited and acquired bleeding disorders, the investigation and management of people with inherited and acquired disorders that predispose them to thrombosis and the management of individuals on a wide variety of anticoagulants.                                                                                              T

he Thrombosis service is a team of specialist nurses who provide a fast track deep vein thrombosis (DVT) assessment service. They also run a daily clinic to facilitate the early discharge of patients with DVT and pulmonary embolism (PE).

CUH (comprising of the Haematology/ Apheresis teams and the Cambridge Cellular Therapy Laboratory) has been selected by NHS England to be one of 10 CAR-T Chimeric Antigen Receptors Cell Therapy centres in the UK.                                                                                                                                        

CAR-T is a highly complex and innovative new treatment. CAR-T is a type of immunotherapy which involves collecting and using the patients’ own immune cells to treat their condition.